文献速递神经肿瘤

内镜与显微镜经蝶窦手术治疗垂体腺瘤的全切率:一项Meta分析

Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.
PubMed 文献 · Acta Neurochir (Wien) · 2018-01-06

该Meta分析纳入至2017年7月的文献,共70个病例系列、8257例垂体腺瘤患者,比较内镜与显微镜经蝶窦手术的全切率。固定效应模型下,内镜组全切率高于显微镜组(74.0% vs 66.4%,P交互<0.01),无功能腺瘤亚组同样更高(71.0% vs 60.7%,P交互<0.01),但随机效应模型下所有关联均不显著。

要点

  • 固定效应模型下内镜经蝶窦手术全切率高于显微镜手术(74.0% vs 66.4%,P交互<0.01)。
  • 无功能垂体腺瘤亚组内镜全切率更高(71.0% vs 60.7%,P交互<0.01),但随机效应模型下不显著。
  • 功能性垂体腺瘤亚组两种术式全切率无显著差异(75.8% vs 75.5%,P交互=0.92)。

核心结论

  • 在非随机分配的患者中,固定效应模型下内镜经蝶窦手术的全切率高于显微镜手术,对全部患者和无功能腺瘤患者均如此。
  • 对于功能性垂体腺瘤,内镜手术似乎并未提供显著更高的全切率。
  • 由于纳入的非对照研究性质,这些结论应谨慎解读。

研究设计与样本

  • 遵循PRISMA指南,检索PubMed、EMBASE和Cochrane数据库至2017年7月的文献进行Meta分析。
  • 共纳入70个报告全切率的病例系列,涉及8257例垂体腺瘤患者。
  • 功能性垂体腺瘤亚组1170例,无功能垂体腺瘤亚组2655例。

主要发现

  • 全部垂体腺瘤:内镜组全切率74.0%(I²=92.1%)vs 显微镜组66.4%(I²=84.0%),固定效应模型P交互<0.01。
  • 功能性垂体腺瘤:内镜组全切率75.8%(I²=63.9%)vs 显微镜组75.5%(I²=79.0%),P交互=0.92。
  • 无功能垂体腺瘤:内镜组全切率71.0%(I²=86.4%)vs 显微镜组60.7%(I²=87.5%),固定效应模型P交互<0.01。
  • 随机效应模型下所有关联均不显著(所有P交互>0.05)。
  • 未发现任何结局存在显著发表偏倚。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些结论应谨慎解读,因为纳入的研究为非对照研究性质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microscopic transsphenoidal surgery (mTSS) is a well-established method to address adenomas of the pituitary gland. Endoscopic transsphenoidal surgery (eTSS) has become a viable alternative, however. Advocates suggest that the greater illumination, panoramic visualization, and angled endoscopic views afforded by eTSS may allow for higher rates of gross total tumor resection (GTR). The aim of this meta-analysis was to determine the rate of GTR using mTSS and eTSS. METHODS: A meta-analysis of the literature was conducted using PubMed, EMBASE, and Cochrane databases through July 2017 in accordance with PRISMA guidelines. RESULTS: Seventy case series that reported GTR rate in 8257 pituitary adenoma patients were identified. For all pituitary adenomas, eTSS (GTR=74.0%; I2 = 92.1%) was associated with higher GTR as compared to mTSS (GTR=66.4%; I2 = 84.0%) in a fixed-effect model (P-interaction < 0.01). For functioning pituitary adenomas (FPAs) (n = 1170 patients), there was no significant difference in GTR rate between eTSS (GTR=75.8%; I2 = 63.9%) and mTSS (GTR=75.5%; I2 = 79.0%); (P-interaction = 0.92). For nonfunctioning pituitary adenomas (NFPAs) (n = 2655 patients), eTSS (GTR=71.0%; I2 = 86.4%) was associated with higher GTR as compared to mTSS (GTR=60.7%; I2 = 87.5%) in a fixed-effect model (P-interaction < 0.01). None of the associations were significant in a random-effect model (all P-interaction > 0.05). No significant publication bias was identified for any of the outcomes. CONCLUSION: Among patients who were not randomly allocated to either approach, eTSS resulted in a higher rate of GTR as compared to mTSS for all patients and for NFPA patients alone, but only in a fixed-effect model. For FPA, however, eTSS did not seem to offer a significantly higher rate of GTR. These conclusions should be interpreted with caution because of the nature of the included non-comparative studies.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Almutairi RD, Muskens IS, Cote DJ, et al. Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir (Wien). 2018. PMID: 29307020. doi:10.1007/s00701-017-3438-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。